Tumor characteristics for primary breast carcinoma analyzed for GIRK1 expression
Case | GIRK1a | CIb | No. of total LN | No. of positive LN | Age (yr) | Size (cm) | Grade | ER |
---|---|---|---|---|---|---|---|---|
805 | 0 | 0–0.07 | 9 | 0 | 52 | 1 | 1 | + |
4046 | 0 | 0–0.03 | 23 | 0 | 52 | 1.1 | 3 | − |
926 | 0.2 | 0.2–0.2 | 18 | 0 | 69 | 1.8 | 3 | + |
2394 | 0.2 | 0.2–0.27 | 10 | 0 | 56 | 1 | 2 | − |
1647 | 0.3 | 0.2–0.3 | 8 | 0 | 37 | 1.8 | 3 | + |
6077 | 0.3 | 0.2–0.6 | 6 | 0 | 54 | 4.5 | 1 | − |
1828 | 0.3 | 0.3–0.37 | 13 | 0 | 66 | 2.2 | 2 | + |
2506 | 0.4 | 0–3.6 | 22 | 0 | 48 | 2.8 | 1 | + |
2495 | 0.4 | 0.3–0.46 | 12 | 0 | 46 | 1 | 1 | + |
3968 | 0.4 | 0.3–0.4 | 11 | 0 | 54 | 2 | 2 | + |
980 | 0.4 | 0.4–0.5 | 8 | 0 | 55 | 2 | 3 | − |
1914 | 0.4 | 0.4–0.6 | 19 | 0 | 64 | 0.9 | 1 | + |
2097 | 0.6 | 0.5–0.6 | 9 | 0 | 54 | 0.9 | 1 | + |
1897 | 0.8 | 0.3–2.0 | 12 | 0 | 55 | 0.8 | 2 | + |
1241 | 0.9 | 0.4–2.2 | 13 | 0 | 81 | 1 | 3 | + |
1740 | 1.1 | 0.9–1.5 | 22 | 0 | 41 | 2.2 | 2 | + |
6757 | 2.8 | 1.9–4.1 | 15 | 0 | 54 | 2.2 | 3 | + |
6263 | 4.1 | 4–4.4 | 8 | 0 | 30 | 0.9 | 2 | + |
4149 | 4.6 | 3.8–5.5 | 6 | 0 | 53 | 1.7 | 3 | + |
4162 | 6.2 | 5.8–9.1 | 19 | 0 | 30 | 1.6 | 3 | − |
2468 | 8.6 | 7.3–10.1 | 12 | 0 | 70 | 4.8 | 2 | + |
5990 | 8.6 | 8.6–10 | 19 | 0 | 59 | 1.4 | 2 | + |
81 | 8.8 | 6.1–12.8 | 13 | 0 | 33 | 1.9 | 1 | + |
5949 | 13.7 | 13.6–14.2 | 14 | 0 | 72 | 0.9 | 2 | + |
6185 | 13.8 | 10.9–17.5 | 19 | 0 | 53 | 1.2 | 2 | + |
6435 | 14.8 | 14.1–15.6 | 11 | 0 | 46 | 1.8 | 2 | + |
939c | 27.4 | 25.6–31 | 11 | 0 | 66 | 1.7 | 2 | + |
2591 | 37.9 | 32.3–44.5 | 12 | 0 | 68 | 1 | 2 | − |
1466 | 39.3 | 32.1–48 | 10 | 0 | 67 | 2 | 3 | + |
4041 | 142.5 | 130.6–156 | 14 | 0 | 66 | 1.6 | 1 | + |
2175 | 0.6 | 0.5–0.7 | 9 | 1 | 71 | 1.5 | 1 | + |
1290 | 0.7 | 0.5–1 | 8 | 1 | 73 | 1.8 | 2 | + |
2588 | 0.7 | 0.6–0.9 | 13 | 1 | 43 | 2 | 1 | + |
7333 | 7.1 | 6.8–7.4 | 18 | 1 | 39 | 1.3 | 2 | + |
6257 | 9.8 | 8.6–11.2 | 8 | 1 | 34 | 1.3 | 3 | − |
3125 | 145.5 | 125.6–201.3 | 15 | 1 | 65 | 3 | 2 | + |
5620 | 186.1 | 165–210 | 8 | 1 | 59 | 1.5 | 1 | + |
4674 | 1.4 | 1.3–1.5 | 10 | 2 | 51 | 2 | 3 | + |
5008 | 148.1 | 147.3–181 | 11 | 2 | 48 | 5.5 | 3 | − |
339 | 335.5 | 302.7–378.6 | 14 | 2 | 51 | 3 | 3 | − |
1375 | 0.93 | 0.7–1.17 | 10 | 2 | 29 | 3.6 | 1 | + |
2151 | 0.1 | 0–0.1 | 7 | 3 | 49 | 1.5 | 3 | + |
585 | 27.7 | 23.9–32 | 8 | 3 | 88 | 4.5 | 2 | + |
7237 | 53.6 | 27.1–119 | 11 | 3 | 59 | 2 | 2 | + |
1191 | 67.6 | 66.3–70.1 | 19 | 3 | 59 | 0.9 | 2 | + |
5893T | 282.1 | 212.1–375 | 20 | 3 | 43 | 5 | 2 | + |
6370T | 0.9 | 0.7–1.2 | 41 | 4 | 46 | 2.5 | 3 | − |
4057 | 704.3 | 658–754 | 5 | 4 | 62 | 1.4 | 2 | + |
3873 | 1.6 | 1.3–2.1 | 21 | 6 | 72 | 3.5 | 3 | − |
6619 | 453.5 | 350.1–588 | 11 | 6 | 69 | 5 | 3 | − |
5 | 0.1 | 0.1–0.2 | 11 | 8 | 73 | 2 | 2 | + |
4106 | 74.3 | 68–81.3 | 12 | 8 | 60 | 2 | 3 | + |
5866 | 89.3 | 82.4–97 | 15 | 8 | 53 | 1.1 | 3 | + |
2153 | 0 | 0–0 | 28 | 13 | 51 | 2 | 2 | − |
3130 | 27.3 | 25.8–29 | 20 | 19 | 46 | 4.4 | 3 | − |
6873 | 9.1 | 7.1–11.7 | 27 | 26 | 84 | 12 | 3 | + |
a Fold increase above control.
b CI (95% confidence intervals); LN, lymph node; ER, estrogen receptor status (as measured by immunohistochemistry); Grade, Bloom Richardson grade.
c Cases shown in bold overexpress GIRK1.